TrialDrug safety2008
Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation.
Dagmar Kubitza et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papertrialcites it